FDA approves first treatment for reactions to multiple foods after accidental exposure
The FDA has approved omalizumab (Xolair) injection as first medication to help reduce allergic reactions to multiple foods after accidental exposure. Omalizumab is a monoclonal antibody that helps reduce certain allergic reactions including anaphylaxis in adults and children 1 year and older. Patients who take Xolair must continue to avoid foods they are allergic to. […]